- call +1-201-465-4211
- email sales@mrinsights.biz
Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
Scope of the Report:
The worldwide market for Alzheimer's Disease Diagnostic is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Alzheimer's Disease Diagnostic in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Genetic testing
Neurological exam
Mini-mental state exam (MMSE)
Brain imaging
Other
Market Segment by Applications, can be divided into
Clinics
Hospitals
Diagnostic Centers
Other
There are 15 Chapters to deeply display the global Alzheimer's Disease Diagnostic market.
Chapter 1, to describe Alzheimer's Disease Diagnostic Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer's Disease Diagnostic, with sales, revenue, and price of Alzheimer's Disease Diagnostic, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer's Disease Diagnostic, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer's Disease Diagnostic market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer's Disease Diagnostic sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alzheimer's Disease Diagnostic Introduction
1.2 Market Analysis by Type
1.2.1 Genetic testing
1.2.2 Neurological exam
1.2.3 Mini-mental state exam (MMSE)
1.2.4 Brain imaging
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Clinics
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Alzheimer's Disease Diagnostic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 TauRx
2.2.1 Business Overview
2.2.2 Alzheimer's Disease Diagnostic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 TauRx Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Alector
2.3.1 Business Overview
2.3.2 Alzheimer's Disease Diagnostic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alector Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Accera
2.4.1 Business Overview
2.4.2 Alzheimer's Disease Diagnostic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Accera Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Treventis
2.5.1 Business Overview
2.5.2 Alzheimer's Disease Diagnostic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Treventis Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Neuro-Bio
2.6.1 Business Overview
2.6.2 Alzheimer's Disease Diagnostic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cognition Therapeutics
2.7.1 Business Overview
2.7.2 Alzheimer's Disease Diagnostic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alzheimer's Disease Diagnostic Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alzheimer's Disease Diagnostic Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer's Disease Diagnostic Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer's Disease Diagnostic Manufacturer Market Share in 2017
3.3.2 Top 6 Alzheimer's Disease Diagnostic Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alzheimer's Disease Diagnostic Market Analysis by Regions
4.1 Global Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer's Disease Diagnostic Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alzheimer's Disease Diagnostic Revenue and Market Share by Regions (2013-2018)
4.2 North America Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
4.3 Europe Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
4.5 South America Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
5 North America Alzheimer's Disease Diagnostic by Countries
5.1 North America Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Countries
5.1.1 North America Alzheimer's Disease Diagnostic Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alzheimer's Disease Diagnostic Revenue and Market Share by Countries (2013-2018)
5.2 United States Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
5.3 Canada Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
5.4 Mexico Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
6 Europe Alzheimer's Disease Diagnostic by Countries
6.1 Europe Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Countries
6.1.1 Europe Alzheimer's Disease Diagnostic Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alzheimer's Disease Diagnostic Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
6.3 UK Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
6.4 France Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
6.5 Russia Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
6.6 Italy Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alzheimer's Disease Diagnostic by Countries
7.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alzheimer's Disease Diagnostic Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alzheimer's Disease Diagnostic Revenue and Market Share by Countries (2013-2018)
7.2 China Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
7.3 Japan Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
7.4 Korea Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
7.5 India Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
8 South America Alzheimer's Disease Diagnostic by Countries
8.1 South America Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Countries
8.1.1 South America Alzheimer's Disease Diagnostic Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alzheimer's Disease Diagnostic Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
8.3 Argentina Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
8.4 Colombia Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alzheimer's Disease Diagnostic by Countries
9.1 Middle East and Africa Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alzheimer's Disease Diagnostic Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alzheimer's Disease Diagnostic Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
9.3 UAE Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
9.4 Egypt Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
9.5 Nigeria Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
9.6 South Africa Alzheimer's Disease Diagnostic Sales and Growth Rate (2013-2018)
10 Global Alzheimer's Disease Diagnostic Market Segment by Type
10.1 Global Alzheimer's Disease Diagnostic Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alzheimer's Disease Diagnostic Sales and Market Share by Type (2013-2018)
10.1.2 Global Alzheimer's Disease Diagnostic Revenue and Market Share by Type (2013-2018)
10.2 Genetic testing Sales Growth and Price
10.2.1 Global Genetic testing Sales Growth (2013-2018)
10.2.2 Global Genetic testing Price (2013-2018)
10.3 Neurological exam Sales Growth and Price
10.3.1 Global Neurological exam Sales Growth (2013-2018)
10.3.2 Global Neurological exam Price (2013-2018)
10.4 Mini-mental state exam (MMSE) Sales Growth and Price
10.4.1 Global Mini-mental state exam (MMSE) Sales Growth (2013-2018)
10.4.2 Global Mini-mental state exam (MMSE) Price (2013-2018)
10.5 Brain imaging Sales Growth and Price
10.5.1 Global Brain imaging Sales Growth (2013-2018)
10.5.2 Global Brain imaging Price (2013-2018)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2013-2018)
10.6.2 Global Other Price (2013-2018)
11 Global Alzheimer's Disease Diagnostic Market Segment by Application
11.1 Global Alzheimer's Disease Diagnostic Sales Market Share by Application (2013-2018)
11.2 Clinics Sales Growth (2013-2018)
11.3 Hospitals Sales Growth (2013-2018)
11.4 Diagnostic Centers Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.1 Global Alzheimer's Disease Diagnostic Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer's Disease Diagnostic Market Forecast by Regions (2018-2023)
12.2.1 North America Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.2.2 Europe Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.2.4 South America Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alzheimer's Disease Diagnostic Market Forecast (2018-2023)
12.3 Alzheimer's Disease Diagnostic Market Forecast by Type (2018-2023)
12.3.1 Global Alzheimer's Disease Diagnostic Sales Forecast by Type (2018-2023)
12.3.2 Global Alzheimer's Disease Diagnostic Market Share Forecast by Type (2018-2023)
12.4 Alzheimer's Disease Diagnostic Market Forecast by Application (2018-2023)
12.4.1 Global Alzheimer's Disease Diagnostic Sales Forecast by Application (2018-2023)
12.4.2 Global Alzheimer's Disease Diagnostic Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alzheimer's Disease Diagnostic Picture
Table Product Specifications of Alzheimer's Disease Diagnostic
Figure Global Sales Market Share of Alzheimer's Disease Diagnos
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
